Sidra’s growing team of nearly 50 medical, scientific and technical pathologists from all over the world is proud to mark International Pathology Day on November 5th. Over the next few weeks, we will focus on the pioneering work that led to the creation of an iconic laboratory assay, the Pap test, including the status of cervical cancer treatment in Qatar and updates about Sidra’s upcoming symposium – “The 1st Century of Gynecological Cytopathology: The Pap Test –Then, Now and the Future”. To begin, we are opening this series by introducing you to the field of pathology, to our team and to the vital role pathologists play in patient care every day.
Pathology focuses on the laboratory testing and analysis of body tissue and fluids for predictive, diagnostic, prognostic and forensic purposes. Interpreting these results can determine the cause and nature of diseases, thereby enabling doctors to diagnose, treat and advise their patents correctly. Patients at Sidra will primarily include a range from unborn babies to expectant moms, and infants to adolescents. Sidra Pathology will play an integral and specialized role focusing on a myriad of medical conditions important to this population – from infertility to prenatal and newborn disease through to cancers and other infectious diseases.
This is an exciting time for the field of pathology as it evolves in an age of new technologies. For instance, histopathology which traditionally uses glass slides studied under a microscope will soon be replaced with digital images, referred to as whole-slide imaging, allowing for virtual management of information and improved sharing of pictures. And with the explosion of new genetic technologies, including high throughput DNA sequencing and microarrays, Sidra Pathology will be working closely with the Research Department to bring cutting edge diagnostic assays to the clinic.
The opportunity to practice in a state-of-the-art center with international colleagues in Sidra’s 52,000 square feet of clinical laboratory space will place Sidra in a position of leadership in the region. Pathologists at Sidra will cover a wide range of disciplines, including anatomical pathology, clinical biochemistry, hematopathology, genetics and microbiology. Our Pathology Department will be equipped to provide rapid and highly accurate disease diagnosis, up to 4,500 automated tests per hour, and many services will be available 24 hours per day.
Aside from the annual International Pathology Day, pathologists the world over are acknowledging November 2014 as the 100-year anniversary of the Pap test, a procedure which has significantly reduced human mortality from cervical cancer through screening and early detection. Conducting their research at Weill Cornell Medical College in New York during the early part of the 20th century, Dr. George N. Papanicolaou and Lady Andromache Papanicolaou started the world on a path that has now made cervical cancer one of the firsts cancers considered preventable thanks to the early diagnosis by Pap testing. The story of this test is a true testament to a wife and husband team’s unwavering dedication to research, to women’s health and to each other, a story you can read about in “Wars Against Cervical Cancer”, written by Sidra’s Cytology Supervisor Nikolaos Chantziantoniou in the Journal of the American Society of Cytopathology.
To take stock of advancements made in the last 100 years and to focus on the future of cervical cancer screening, Sidra Pathology is organizing the “The 1st Century of Gynecological Cytopathology: The Pap Test –Then, Now and the Future” seminar on Sunday, 7 December at the Four Season Hotel in Doha. For more details please email email@example.com.